Astellas Pharma Ltd

3rd Floor, Future House, The Glanty, Egham, Surrey, TW20 9AH
Telephone: +44 (0)1784 419615
Fax: +44 (0)1784 419583
Medical Information Direct Line: 0800 783 5018
Medical Information e-mail: medinfo@gb.astellas.com


Summary of Product Characteristics last updated on the eMC: 13/04/2011
SPC Conotrane Cream


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Conotrane Cream.


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

A smooth white cream containing benzalkonium chloride 0.1% w/w and Dimeticone 22.0% w/w.


Go to top of the page
3. PHARMACEUTICAL FORM

Cream for topical administration.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

Conotrane is used for protection of the skin from moisture, irritants, chafing and contamination with bacteria or yeasts.

It may be used in situations such as in the prevention/treatment of napkin rash, the prevention of pressure sores and in the management of incontinence.


Go to top of the page
4.2 Posology and method of administration

The cream should be applied to the affected area several times a day, as necessary or after every napkin change.


Go to top of the page
4.3 Contraindications

Known hypersensitivity to benzalkonium chloride.


Go to top of the page
4.4 Special warnings and precautions for use

Cetostearyl alcohol may cause local skin reactions (e.g. contact dermatitis).


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None stated.


Go to top of the page
4.6 Pregnancy and lactation

Not applicable.


Go to top of the page
4.7 Effects on ability to drive and use machines

None stated.


Go to top of the page
4.8 Undesirable effects

Local hypersensitivity to benzalkonium chloride is rare.


Go to top of the page
4.9 Overdose

Not applicable.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

This is a remedy suitable for both prescription and for self medication. It is a cream for topical application containing dimeticone and benzalkonium chloride. The dimeticone is water repellent allowing transpiration of water vapour from the skin. The benzalkonium chloride is a quaternary ammonium compound, active against bacteria and yeasts.


Go to top of the page
5.2 Pharmacokinetic properties

Not applicable.


Go to top of the page
5.3 Preclinical safety data

None stated.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Cetostearyl alcohol

Macrogol cetostearyl ether

White soft paraffin

Light liquid paraffin

Deionised water

Macrogol 300

Potassium dihydrogen orthophosphate

Geranium SC45


Go to top of the page
6.2 Incompatibilities

None stated.


Go to top of the page
6.3 Shelf life

3 years.


Go to top of the page
6.4 Special precautions for storage

Do not store above 25°C.


Go to top of the page
6.5 Nature and contents of container

(i) 7 g, 15 g, 50 g and 100 g in white LDPE tubes.

(ii) 500 g white polypropylene pot with screw lid.


Go to top of the page
6.6 Special precautions for disposal and other handling

None stated.


Go to top of the page
Administrative Data

Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Astellas Pharma Ltd.

3rd Floor

Future House

The Glanty

Egham

Surrey

TW20 9AH

United Kingdom


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 0166/0178.


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

1 July 1998 / 16th July 2003


Go to top of the page
10. DATE OF REVISION OF THE TEXT

13th December 2010


Go to top of the page
11. Legal category

GSL



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/2252/SPC/


Active Ingredients/Generics

 
   dimeticone
   benzalkonium chloride